Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma

MA Jiao; HUO Jingyu; HAN Caiyun

doi:10.7619/jcmp.20242394

Journal of Clinical Medicine in Practice > 2025 > 29(3): 118-122. > DOI: 10.7619/jcmp.20242394

MA Jiao, HUO Jingyu, HAN Caiyun. Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 118-122. DOI: 10.7619/jcmp.20242394

Citation:

PDF (639 KB)

Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma

1.
Department of Pediatrics, Xingyuan Hospital of Yulin of Shaanxi Province, Yulin, Shaanxi, 719051
2.
Department of Pediatrics, the First Hospital of Yulin of Shaanxi Province, Yulin, Shaanxi, 718099

More Information

Received Date: June 05, 2024
Revised Date: September 10, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the correlations of serum dual-specific phosphatase 1 (DUSP1) and soluble cluster of differentiation 93 (sCD93) with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma (BA).
Methods
A total of 100 children with acute-phase BA (acute-phase group), 100 children with remission-phase BA (remission-phase group), and 100 healthy children (control group) in the Xingyuan Hospital of Yulin from January 2021 to January 2023 were selected, and the acute-phase group was further divided into mild subgroup (n=47), moderate subgroup (n=36) and severe subgroup (n=17) according to the severity of the disease. Serum DUSP1, sCD93 levels and lung function indexes [peak expiratory flow (PEF), percentage of forced expiratory volume in the first second compared to the expected value (FEV₁%pred)], and airway inflammation indexes [eosinophil (EOS) count, fractional exhaled nitric oxide (FeNO)] were measured. Pearson's method was used to analyze the correlations of serum DUSP1 and sCD93 levels with PEF, FEV₁%pred, EOS and FeNO in children with acute-phase BA.
Results
The levels of serum DUSP1, PEF, and FEV₁%pred in the acute-phase group were significantly lower than those in the remission-phase group and the control group, while the levels of sCD93, EOS count and FeNO were significantly higher than those in the remission-phase group and the control group (P < 0.01). The levels of serum DUSP1, PEF and FEV₁%pred in the severe subgroup were significantly lower than those in the moderate and mild subgroups, while the levels of sCD93, EOS count and FeNO were significantly higher than those in the moderate and mild subgroups (P < 0.01). PEF and FEV₁%pred were positively correlated with serum DUSP1 level, but negatively correlated with sCD93 level in children with acute-phase BA (P < 0.01). EOS count and FeNO were negatively correlated with serum DUSP1 level, but positively correlated with sCD93 level (P < 0.01).
Conclusions
The decreased serum DUSP1 level and increased sCD93 level in children with acute-phase BA are closely related to the aggravation of the disease, the decrease of lung function, and airway inflammation, which may become new targets for the treatment of children with acute-phase BA.
- children,
- bronchial asthma,
- dual-specific phosphatase 1,
- soluble cluster of differentiation 93,
- severity of disease,
- lung function,
- airway inflammation

FullText(HTML)

References (25)

References

[1]	中国中西医结合学会呼吸病专业委员会. 支气管哮喘中西医结合诊疗中国专家共识[J]. 中国中西医结合杂志, 2023, 43(1): 12-20.
[2]	周舒, 黄嘉, 梁雅丽, 等. 中国儿童哮喘患病率及其危险因素的Meta分析[J]. 国际流行病学传染病学杂志, 2020, 47(3): 253-259.
[3]	中国医药教育协会儿科专业委员会, 中华医学会儿科学分会呼吸学组哮喘协作组, 中国医师协会呼吸医师分会儿科呼吸工作委员会, 等. 中国儿童支气管哮喘诊治现状及发展策略(2022)[J]. 中华实用儿科临床杂志, 2023, 38(9): 647-680.
[4]	中华儿科杂志编辑委员会, 中华医学会儿科学分会呼吸学组, 中国医师协会儿科医师分会儿童呼吸专业委员会. 儿童支气管哮喘规范化诊治建议(2020年版)[J]. 中华儿科杂志, 2020, 58(9): 708-717.
[5]	SUN F, YUE T T, YANG C L, et al. The MAPK dual specific phosphatase (DUSP) proteins: a versatile wrestler in T cell functionality[J]. Int Immunopharmacol, 2021, 98: 107906. doi: 10.1016/j.intimp.2021.107906
[6]	THEODOROU J, NOWAK E, BÖCK A, et al. Mitogen-activated protein kinase signaling in childhood asthma development and environment-mediated protection[J]. Pediatr Allergy Immunol, 2022, 33(1): e13657. doi: 10.1111/pai.13657
[7]	TOSSETTA G, PIANI F, BORGHI C, et al. Role of CD93 in health and disease[J]. Cells, 2023, 12(13): 1778. doi: 10.3390/cells12131778
[8]	ÖSTLING J, VAN GEEST M, OLSSON H K, et al. A novel non-invasive method allowing for discovery of pathologically relevant proteins from small airways[J]. Clin Proteomics, 2022, 19(1): 20. doi: 10.1186/s12014-022-09348-y
[9]	中华医学会呼吸病学分会哮喘学组, 周新, 沈华浩, 等. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12): 1023-1048.
[10]	国家呼吸系统疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组哮喘协作组, 中国医药教育协会儿科专业委员会, 等. 中国儿童哮喘行动计划临床应用专家共识[J]. 中华实用儿科临床杂志, 2021, 36(7): 484-490.
[11]	伊娜, 刘婷婷, 周宇畅, 等. 1990—2019年中国儿童青少年哮喘疾病负担分析[J]. 中华流行病学杂志, 2023, 44(2): 235-242.
[12]	陈奕帆, 王雨欣, 顾雨菲, 等. 支气管哮喘气道炎症损伤中免疫失衡的研究进展[J]. 中国医科大学学报, 2023, 52(4): 371-374.
[13]	中华医学会儿科学分会呼吸学组哮喘协作组. 儿童呼出气一氧化氮检测及临床应用专家共识(2021版)[J]. 中华实用儿科临床杂志, 2021, 36(6): 417-423.
[14]	SIDDIQUI S, BACHERT C, BJERMER L, et al. Eosinophils and tissue remodeling: relevance to airway disease[J]. J Allergy Clin Immunol, 2023, 152(4): 841-857.
[15]	李昂, 皇惠杰, 杨世青, 等. 长程治疗管理哮喘儿童的肺功能轨迹特征分析[J]. 首都医科大学学报, 2022, 43(6): 940-947.
[16]	ZHENG R, DU M L, TIAN M, et al. Fine particulate matter induces childhood asthma attacks via extracellular vesicle-packaged let-7i-5p-mediated modulation of the MAPK signaling pathway[J]. Adv Sci, 2022, 9(3): e2102460.
[17]	LIANG L, LI F, BAO A H, et al. Activation of p38 mitogen-activated protein kinase in ovalbumin and ozone-induced mouse model of asthma[J]. Respirology, 2013, 18(Suppl 3): 20-29.
[18]	ZHOU L, FANG L, TAMM M, et al. Extracellular heat shock protein 70 increases the glucocorticoid receptor and dual-specificity phosphatase 1 via toll-like receptor 4 and attenuates inflammation in airway epithelial cells[J]. Int J Mol Sci, 2023, 24(14): 11700.
[19]	中华医学会变态反应学分会. 2型炎症性疾病机制及靶向治疗专家共识[J]. 中华医学杂志, 2022, 102(42): 3349-3373.
[20]	PEMMARI A, PAUKKERI E L, HÄMÄLÄINEN M, et al. MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids[J]. Basic Clin Pharmacol Toxicol, 2019, 124(4): 404-415.
[21]	PARK H J, OH E Y, PARK Y H, et al. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model[J]. Biomarkers, 2018, 23(5): 446-452.
[22]	PARK H J, OH E Y, HAN H J, et al. Soluble CD93 in allergic asthma[J]. Sci Rep, 2020, 10(1): 323.
[23]	SIGARI N, JALILI A, MAHDAWI L, et al. Soluble CD93 as a novel biomarker in asthma exacerbation[J]. Allergy Asthma Immunol Res, 2016, 8(5): 461-465.
[24]	PARK H J, HAN H, LEE S C, et al. Soluble CD93 in serum as a marker of allergic inflammation[J]. Yonsei Med J, 2017, 58(3): 598-603.
[25]	HONG X, XIA M J, ZHANG Q Y, et al. Deficiency of CD93 exacerbates inflammation-induced activation and migration of BV2 microglia by regulating the TAK1/NF-κB pathway[J]. Neurosci Lett, 2022, 791: 136914.

[1]	LI Jinpei, WANG Yonghuai, LI Guangyuan, MA Chunyan, YANG Jun. Research progress on risk factors of coronary slow flow[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 115-118. DOI: 10.7619/jcmp.20220353
[2]	CHEN Haiyan, FU Xiaodan, ZHANG Qiuju. Relationships of indicators such as level of plasma lipoprotein-associated phospholipase A2 with effect of extracorporeal counterpulsation therapy in high-risk patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 63-67. DOI: 10.7619/jcmp.20214222
[3]	GONG Xiaoyong, HU Xiaowei, HE Fei, HU Jianping. Correlations between serum levels of brain natriuretic peptide, hypersensitive C-reactive protein as well as creatine kinase isoenzyme and prognosis of patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 72-76. DOI: 10.7619/jcmp.20211053
[4]	LI Jiancheng, XU Gangzheng. Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 34-36. DOI: 10.7619/jcmp.202018009
[5]	WANG Dong. Effect of maixuekang capsule combined with percutaneous coronary intervention on platelet aggregation rate and high sensitivity C-reactive protein in patients with acute coronarysyndrome[J]. Journal of Clinical Medicine in Practice, 2018, (5): 42-44. DOI: 10.7619/jcmp.201805013
[6]	WANG Yanhua. Clinical significance of changes in levels of high sensitive C-reactive protein and cardiac troponin-T in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2015, (7): 29-31. DOI: 10.7619/jcmp.201507007
[7]	WANG Junjun, YU Chunjuan, DING Qilong, XING Ting. Correlation between serum high sensitivity C-reactive protein and atherosclerosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (5): 5-7. DOI: 10.7619/jcmp.201505002
[8]	CAI Guodong, GU Yang, LIU Shengshan, ZHU Hairong. Change and significance of plasma lipoprotein-associated phospholipase A2 and Lipoprotein(a)levels in atherosclerotic cerebral infraction[J]. Journal of Clinical Medicine in Practice, 2014, (16): 18-21. DOI: 10.7619/jcmp.201416005
[9]	Application of high sensitivity C-reactive protein and pressure wire in dealing with critical lesion during coronary artery intervention[J]. Journal of Clinical Medicine in Practice, 2013, (21): 12-15. DOI: 10.7619/jcmp.201321004
[10]	ZHANG Ying, QIN Shu, ZHANG Dongyin, WANG Kechun. Relationship between high-sensitivity C-reactive protein and the severity and prognosis of coronary atherosclerosis of coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2012, (23): 45-48.

Cited By

Cited by

Periodical cited type(11)

1.	刘亚男，房志琴，郭健宏，王亚玲. 冠状动脉慢血流患者血清Lp-PLA_2、NLR水平变化及临床意义. 广东医学. 2024(06): 717-722 .
2.	朱雅男，张志强，徐继方，朱云霞，安梦秋. 冠状动脉慢血流的相关血清学分析. 心肺血管病杂志. 2023(01): 23-26 .
3.	孙晓慧，贺静，王瑶，白蓉，薛晓珍，杨莉，乌宇亮. 血清脂蛋白相关磷脂酶A2水平与冠状动脉病变程度及慢血流的相关性分析. 临床医学研究与实践. 2023(26): 9-12 .
4.	师志芳，贾营，张秀敬，谭化，王爱民，赵洁. 血清血小板活化因子和脂蛋白相关磷脂酶AA2对冠状动脉慢血流现象的预测价值分析. 中国心血管病研究. 2023(12): 1080-1085 .
5.	梁万添，唐良秋，陈锦峰，庞军刚，周婉明，陈伟强，陈姣. 小檗碱对急性心肌梗死经皮冠状动脉介入术后冠状动脉不稳定斑块的治疗作用. 中国医药. 2021(01): 28-32 .
6.	刘玲玲，韩磊. 冠状动脉慢血流与超敏CRP及左室舒张功能的相关性研究. 中国医药指南. 2021(22): 11-13 .
7.	朱宝华，孙岩. 冠状动脉疾病差异基因富集和加权基因共表达网络分析. 实用临床医药杂志. 2021(17): 15-21 . 本站查看
8.	陶金松，李健，徐霞，陆翊超，李伟章. 冠心病患者介入术中并发冠状动脉慢血流的影响因素. 现代医学与健康研究电子杂志. 2021(19): 93-95 .
9.	陆爱民，童有福，赵艳. 利伐沙班对冠状动脉慢血流患者凝血功能及C反应蛋白的影响. 医学综述. 2021(21): 4354-4359 .
10.	孙涛，张艳丽，侯梅凤，姚成俊，潘闽. 血清脂蛋白(a)[Lp(a)]、血清超敏C反应蛋白（hs-CRP）与冠状动脉慢血流之间的相关性. 系统医学. 2021(22): 32-36 .
11.	陈艳俏，程伟，张成英，陈少军，马友合，孙久林. 保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察. 中国中医药现代远程教育. 2020(19): 70-73 .

Other cited types(0)

Get Citation

PDF

XML

Article views PDF downloads Cited by(11)

Turn off MathJax

Article Contents

Abstract

References

Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma

Abstract

References

Related Articles

Cited by

Periodical cited type(11)

Other cited types(0)

Catalog

Correlations of serum dual-specific phosphatase 1 and soluble cluster of differentiation 93 with severity of disease, lung function and airway inflammation in children with acute-phase bronchial asthma

Abstract

References

Related Articles

Cited by

Periodical cited type(11)

Other cited types(0)

Catalog

Export File

Citation

Format

Content